Genmab A/S Sustainability Reports

Genmab A/S is an international biotechnology company specializing in the creation and development of differentiated antibody therapeutics. The company primarily targets the treatment of cancer and other serious diseases using next-generation antibody technologies.

Sector: Professional & technical services

Country: Denmark

Exchange: Nasdaq Copenhagen

ISIN: DK0010272202

23 reports from 2007 to 2025

• Genmab A/S 2025 Statutory Corporate Governance Report
• Genmab A/S 2024 Annual Report
• Genmab A/S 2024 Corporate Responsibility and Sustainability Highlights
• Genmab A/S 2023 Corporate Responsibility Report
• Genmab A/S 2023 Annual Report